Clinical trial
Modification of Threat Interpretation Bias to Reduce Anxiety in Neurodegenerative Movement Disorders (Aim 3)
NCT07213648 is registered in ClinicalTrials.gov with University of Virginia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Modification of Threat Interpretation Bias to Reduce Anxiety in Neurodegenerative Movement Disorders (Aim 3)
- Lead sponsor
- University of Virginia
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- November 20, 2025
- Completion date
- September 30, 2026
- Enrollment
- 136 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.